Which stocks in any sector do Indian mutual fund managers prefer most? — April 2026 data
| # | Stock Name | No. of MFs Holding | Avg Weight (%) | Total MF Value (Cr) |
|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 398 funds | 2.61% | ₹48,600 Cr |
| 2 | Divi's Laboratories Limited | 272 funds | 2.16% | ₹21,494 Cr |
| 3 | Cipla Limited | 236 funds | 1.60% | ₹19,555 Cr |
| 4 | Dr. Reddy's Laboratories Limited | 222 funds | 1.73% | ₹14,265 Cr |
| 5 | Lupin Limited | 220 funds | 1.72% | ₹17,415 Cr |
| 6 | Torrent Pharmaceuticals Limited | 205 funds | 1.50% | ₹5,830 Cr |
| 7 | Mankind Pharma Limited | 179 funds | 1.18% | ₹9,924 Cr |
| 8 | Glenmark Pharmaceuticals Limited | 169 funds | 1.56% | ₹9,000 Cr |
| 9 | Aurobindo Pharma Limited | 164 funds | 1.45% | ₹8,314 Cr |
| 10 | Abbott India Limited | 151 funds | 0.95% | ₹3,965 Cr |
| 11 | Alkem Laboratories Limited | 151 funds | 1.25% | ₹10,196 Cr |
| 12 | Ajanta Pharma Limited | 140 funds | 0.90% | ₹5,025 Cr |
| 13 | Laurus Labs Limited | 137 funds | 1.75% | ₹4,830 Cr |
| 14 | IPCA Laboratories Limited | 137 funds | 1.13% | ₹12,014 Cr |
| 15 | JB Chemicals & Pharmaceuticals Limited | 136 funds | 1.34% | ₹5,810 Cr |
| 16 | Biocon Limited | 134 funds | 1.04% | ₹9,355 Cr |
| 17 | Sai Life Sciences Limited | 122 funds | 1.27% | ₹6,257 Cr |
| 18 | Anthem Biosciences Limited | 120 funds | 0.71% | ₹3,547 Cr |
| 19 | Zydus Lifesciences Limited | 117 funds | 0.77% | ₹3,598 Cr |
| 20 | Gland Pharma Limited | 110 funds | 1.03% | ₹8,572 Cr |
The table above ranks the top 20 stocks in the Pharmaceuticals & Biotechnology sector by the number of Indian mutual fund schemes holding them as of April 2026. When a large number of fund managers independently choose the same stock, it is a powerful signal of institutional conviction — these are the stocks that professional money managers believe in most.
A stock held by 200+ mutual funds means that hundreds of fund managers — each doing their own independent research — have concluded that this stock deserves a place in their portfolio. This collective wisdom is one of the most reliable indicators of a stock's quality within its sector. The average weight shows how much of their portfolio each fund typically allocates to the stock, and the total MF value shows the combined rupee investment across all funds holding it.
All data is sourced from monthly portfolio disclosures that every AMFI-registered mutual fund is required to publish. RightAdvise compiles and analyses this data across 1,100+ active fund schemes to give you a clear, unbiased view of where professional fund managers are investing in the Pharmaceuticals & Biotechnology sector. Click any stock name in the table to see which specific funds hold it and in what proportion.